{
    "title": "Alcobra ADHD drug meets goals, after data excluded; stock tanks",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2782258/Alcobras-ADHD-drug-meets-goals-excluding-data.html",
    "date": "2014-10-06",
    "keywords": [
        "drug",
        "company",
        "study",
        "percent",
        "stock",
        "october",
        "vidya",
        "l",
        "market",
        "attention",
        "deficit",
        "disorder",
        "phase",
        "metadoxine",
        "treatment",
        "adhd",
        "placebo",
        "gmt",
        "email",
        "value",
        "adult",
        "trial",
        "loser",
        "nasdaq",
        "belief",
        "capital",
        "debjit",
        "chattopadhyay",
        "low",
        "capitalizationalcobra",
        "ceo",
        "deal",
        "december",
        "shire",
        "plc",
        "river",
        "hyperactivity",
        "condition",
        "adultsadhd",
        "childhood",
        "adulthood",
        "disease",
        "control",
        "preventionthe",
        "improvement",
        "scale",
        "saidalcobra",
        "food",
        "administration",
        "development",
        "latestage",
        "rationale",
        "evidence",
        "fda",
        "subscale",
        "class",
        "nerve",
        "number",
        "release",
        "acid",
        "chemical",
        "straterra",
        "warning",
        "risk",
        "vynase",
        "half",
        "yearjohnson",
        "brought",
        "reporting",
        "nathan",
        "bangalore",
        "editing",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}